-
1
-
-
0034663039
-
The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity
-
Ostrerova-Golts N., Petrucelli L., Hardy J., Lee J.M., Farer M., Wolozin B. The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. JNeurosci 2000, 20:6048-6054.
-
(2000)
JNeurosci
, vol.20
, pp. 6048-6054
-
-
Ostrerova-Golts, N.1
Petrucelli, L.2
Hardy, J.3
Lee, J.M.4
Farer, M.5
Wolozin, B.6
-
2
-
-
0036400025
-
Ceruloplasmin metabolism and function
-
Hellman N.E., Gitlin J.D. Ceruloplasmin metabolism and function. Annu Rev Nutr 2002, 22:439-458.
-
(2002)
Annu Rev Nutr
, vol.22
, pp. 439-458
-
-
Hellman, N.E.1
Gitlin, J.D.2
-
3
-
-
0038711587
-
Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system
-
Jeong S.Y., David S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. JBiol Chem 2003, 278:27144-27148.
-
(2003)
JBiol Chem
, vol.278
, pp. 27144-27148
-
-
Jeong, S.Y.1
David, S.2
-
4
-
-
84856370491
-
Immune cells and hepatocytes express glycosylphosphatidylinositol-anchored ceruloplasmin at their cell surface
-
Marques L., Auriac A., Willemetz A., Banha J., Silva B., Canonne-Hergaux F., et al. Immune cells and hepatocytes express glycosylphosphatidylinositol-anchored ceruloplasmin at their cell surface. Blood Cells Mol Dis 2012, 48:110-120.
-
(2012)
Blood Cells Mol Dis
, vol.48
, pp. 110-120
-
-
Marques, L.1
Auriac, A.2
Willemetz, A.3
Banha, J.4
Silva, B.5
Canonne-Hergaux, F.6
-
5
-
-
83455177604
-
Ceruloplasmin oxidation, a feature of Parkinson's disease CSF, inhibits ferroxidase activity and promotes cellular iron retention
-
Olivieri S., Conti A., Iannaccone S., Cannistraci C.V., Campanella A., Barbariga M., et al. Ceruloplasmin oxidation, a feature of Parkinson's disease CSF, inhibits ferroxidase activity and promotes cellular iron retention. JNeurosci 2011, 31:18568-18577.
-
(2011)
JNeurosci
, vol.31
, pp. 18568-18577
-
-
Olivieri, S.1
Conti, A.2
Iannaccone, S.3
Cannistraci, C.V.4
Campanella, A.5
Barbariga, M.6
-
6
-
-
78649519833
-
Case-control studies on ceruloplasmin and superoxide dismutase (SOD1) in neurodegenerative diseases: a short review
-
Torsdottir G., Kristinsson J., Snaedal J., Sveinbjornsdottir S., Gudmundsson G., Hreidarsson S., et al. Case-control studies on ceruloplasmin and superoxide dismutase (SOD1) in neurodegenerative diseases: a short review. JNeurol Sci 2010, 299:51-54.
-
(2010)
JNeurol Sci
, vol.299
, pp. 51-54
-
-
Torsdottir, G.1
Kristinsson, J.2
Snaedal, J.3
Sveinbjornsdottir, S.4
Gudmundsson, G.5
Hreidarsson, S.6
-
7
-
-
0033597299
-
Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease
-
Boll M.C., Sotelo J., Otero E., Alcaraz-Zubeldia M., Rios C. Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease. Neurosci Lett 1999, 265:155-158.
-
(1999)
Neurosci Lett
, vol.265
, pp. 155-158
-
-
Boll, M.C.1
Sotelo, J.2
Otero, E.3
Alcaraz-Zubeldia, M.4
Rios, C.5
-
8
-
-
84878398613
-
Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease
-
Ayton S., Lei P., Duce J.A., Wong B.X., Sedjahtera A., Adlard P.A., et al. Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease. Ann Neurol 2013, 73:554-559.
-
(2013)
Ann Neurol
, vol.73
, pp. 554-559
-
-
Ayton, S.1
Lei, P.2
Duce, J.A.3
Wong, B.X.4
Sedjahtera, A.5
Adlard, P.A.6
-
9
-
-
67349173208
-
Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson's disease
-
Bharucha K.J., Friedman J.K., Vincent A.S., Ross E.D. Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson's disease. JNeurol 2008, 255:1957-1962.
-
(2008)
JNeurol
, vol.255
, pp. 1957-1962
-
-
Bharucha, K.J.1
Friedman, J.K.2
Vincent, A.S.3
Ross, E.D.4
-
10
-
-
78650695967
-
Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease
-
Jin L., Wang J., Zhao L., Jin H., Fei G., Zhang Y., et al. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease. Brain 2011, 134:50-58.
-
(2011)
Brain
, vol.134
, pp. 50-58
-
-
Jin, L.1
Wang, J.2
Zhao, L.3
Jin, H.4
Fei, G.5
Zhang, Y.6
-
11
-
-
84862799577
-
Nigral iron deposition occurs across motor phenotypes of Parkinson's disease
-
Jin L., Wang J., Jin H., Fei G., Zhang Y., Chen W., et al. Nigral iron deposition occurs across motor phenotypes of Parkinson's disease. Eur J Neurol 2012, 19:969-976.
-
(2012)
Eur J Neurol
, vol.19
, pp. 969-976
-
-
Jin, L.1
Wang, J.2
Jin, H.3
Fei, G.4
Zhang, Y.5
Chen, W.6
-
12
-
-
80054992416
-
Plasma ceruloplasmin ferroxidase activity correlates with the nigral sonographic area in Parkinson's disease patients: a pilot study
-
Martinez-Hernandez R., Montes S., Higuera-Calleja J., Yescas P., Boll M.C., Diaz-Ruiz A., et al. Plasma ceruloplasmin ferroxidase activity correlates with the nigral sonographic area in Parkinson's disease patients: a pilot study. Neurochem Res 2011, 36:2111-2115.
-
(2011)
Neurochem Res
, vol.36
, pp. 2111-2115
-
-
Martinez-Hernandez, R.1
Montes, S.2
Higuera-Calleja, J.3
Yescas, P.4
Boll, M.C.5
Diaz-Ruiz, A.6
-
13
-
-
0028040512
-
Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions
-
Petrukhin K., Lutsenko S., Chernov I., Ross B.M., Kaplan J.H., Gilliam T.C. Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative splicing, and structure/function predictions. Hum Mol Genet 1994, 3:1647-1656.
-
(1994)
Hum Mol Genet
, vol.3
, pp. 1647-1656
-
-
Petrukhin, K.1
Lutsenko, S.2
Chernov, I.3
Ross, B.M.4
Kaplan, J.H.5
Gilliam, T.C.6
-
14
-
-
0035097871
-
Is Parkinson's disease the heterozygote form of Wilson's disease: PD= 1/2 WD?
-
Johnson S. Is Parkinson's disease the heterozygote form of Wilson's disease: PD= 1/2 WD?. Med Hypotheses 2001, 56:171-173.
-
(2001)
Med Hypotheses
, vol.56
, pp. 171-173
-
-
Johnson, S.1
-
15
-
-
70349229546
-
Hypoceruloplasminemia-related movement disorder without Kayser-Fleischer rings is different from Wilson disease and not involved in ATP7B mutation
-
Lirong J., Jianjun J., Hua Z., Guoqiang F., Yuhao Z., Xiaoli P., et al. Hypoceruloplasminemia-related movement disorder without Kayser-Fleischer rings is different from Wilson disease and not involved in ATP7B mutation. Eur J Neurol 2009, 16:1130-1137.
-
(2009)
Eur J Neurol
, vol.16
, pp. 1130-1137
-
-
Lirong, J.1
Jianjun, J.2
Hua, Z.3
Guoqiang, F.4
Yuhao, Z.5
Xiaoli, P.6
-
16
-
-
0035955374
-
Identification of novel genes coding for small expressed RNAs
-
Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294:853-858.
-
(2001)
Science
, vol.294
, pp. 853-858
-
-
Lagos-Quintana, M.1
Rauhut, R.2
Lendeckel, W.3
Tuschl, T.4
-
17
-
-
58249088751
-
MicroRNAs: target recognition and regulatory functions
-
Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
-
(2009)
Cell
, vol.136
, pp. 215-233
-
-
Bartel, D.P.1
-
18
-
-
11844278458
-
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
-
Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
-
(2005)
Cell
, vol.120
, pp. 15-20
-
-
Lewis, B.P.1
Burge, C.B.2
Bartel, D.P.3
-
19
-
-
34548537573
-
AmicroRNA feedback circuit in midbrain dopamine neurons
-
Kim J., Inoue K., Ishii J., Vanti W.B., Voronov S.V., Murchison E., et al. AmicroRNA feedback circuit in midbrain dopamine neurons. Science 2007, 317:1220-1224.
-
(2007)
Science
, vol.317
, pp. 1220-1224
-
-
Kim, J.1
Inoue, K.2
Ishii, J.3
Vanti, W.B.4
Voronov, S.V.5
Murchison, E.6
-
20
-
-
84859500773
-
MicroRNAs in Parkinson's disease
-
Mouradian M.M. MicroRNAs in Parkinson's disease. Neurobio Dis 2012, 46:279-284.
-
(2012)
Neurobio Dis
, vol.46
, pp. 279-284
-
-
Mouradian, M.M.1
-
21
-
-
84872288330
-
Plasma microRNA biomarkers for detection of mild cognitive impairment
-
Sheinerman K.S., Tsivinsky V.G., Crawford F., Mullan M.J., Abdullah L., Umansky S.R. Plasma microRNA biomarkers for detection of mild cognitive impairment. Aging 2012, 4:590-605.
-
(2012)
Aging
, vol.4
, pp. 590-605
-
-
Sheinerman, K.S.1
Tsivinsky, V.G.2
Crawford, F.3
Mullan, M.J.4
Abdullah, L.5
Umansky, S.R.6
-
22
-
-
0032937059
-
Diagnostic criteria for Parkinson disease
-
Gelb D.J., Oliver E., Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999, 56:33-39.
-
(1999)
Arch Neurol
, vol.56
, pp. 33-39
-
-
Gelb, D.J.1
Oliver, E.2
Gilman, S.3
-
23
-
-
0014082977
-
Parkinsonism: onset, progression and mortality
-
Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 1967, 17:427-442.
-
(1967)
Neurology
, vol.17
, pp. 427-442
-
-
Hoehn, M.M.1
Yahr, M.D.2
-
25
-
-
84876183915
-
MiRNAs and their putative roles in the development and progression of Parkinson's disease
-
Wong G., Nass R. miRNAs and their putative roles in the development and progression of Parkinson's disease. Front Genet 2012, 3:315.
-
(2012)
Front Genet
, vol.3
, pp. 315
-
-
Wong, G.1
Nass, R.2
-
26
-
-
84864862893
-
Normal midbrain dopaminergic neuron development and function in miR-133b mutant mice
-
Heyer M.P., Pani A.K., Smeyne R.J., Kenny P.J., Feng G. Normal midbrain dopaminergic neuron development and function in miR-133b mutant mice. JNeurosci 2012, 32:10887-10894.
-
(2012)
JNeurosci
, vol.32
, pp. 10887-10894
-
-
Heyer, M.P.1
Pani, A.K.2
Smeyne, R.J.3
Kenny, P.J.4
Feng, G.5
-
27
-
-
77956122651
-
Analysis of the Micro-RNA-133 and PITX3 genes in Parkinson's disease
-
de Mena L., Coto E., Cardo L.F., Diaz M., Biazquez M., Ribacoba R., et al. Analysis of the Micro-RNA-133 and PITX3 genes in Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet 2010, 153B:1234-1239.
-
(2010)
Am J Med Genet B Neuropsychiatr Genet
, vol.153 B
, pp. 1234-1239
-
-
de Mena, L.1
Coto, E.2
Cardo, L.F.3
Diaz, M.4
Biazquez, M.5
Ribacoba, R.6
-
28
-
-
84874894477
-
Plasma-based circulating MicroRNA biomarkers for Parkinson's disease
-
Khoo S.K., Petillo D., Kang U.J., Resau J.H., Berryhill B., Linder J., et al. Plasma-based circulating MicroRNA biomarkers for Parkinson's disease. JPark Dis 2012, 2:321-331.
-
(2012)
JPark Dis
, vol.2
, pp. 321-331
-
-
Khoo, S.K.1
Petillo, D.2
Kang, U.J.3
Resau, J.H.4
Berryhill, B.5
Linder, J.6
-
29
-
-
0028903259
-
Aceruloplasminemia: molecular characterization of this disorder of iron metabolism
-
Harris Z.L., Takahashi Y., Miyajima H., Serizawa M., MacGillivray R.T., Gitlin J.D. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci U S A 1995, 92:2539-2543.
-
(1995)
Proc Natl Acad Sci U S A
, vol.92
, pp. 2539-2543
-
-
Harris, Z.L.1
Takahashi, Y.2
Miyajima, H.3
Serizawa, M.4
MacGillivray, R.T.5
Gitlin, J.D.6
-
30
-
-
0036703490
-
Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury
-
Patel B.N., Dunn R.J., Jeong S.Y., Zhu Q., Julien J.P., David S. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. JNeurosci 2002, 22:6578-6586.
-
(2002)
JNeurosci
, vol.22
, pp. 6578-6586
-
-
Patel, B.N.1
Dunn, R.J.2
Jeong, S.Y.3
Zhu, Q.4
Julien, J.P.5
David, S.6
|